Featured
Pre-Clinical Phase
Collects data to support feasibility and safety
Involves iterative animals testing such as mice or
monkeys to see if it produces an immune response.
Evaluates toxic and pharmacological effects
Normally occurs before human testing can begin
Sponsored content...
The FDA announced it had amended
the emergency use authorizations for both the Moderna and Pfizer-BioNTech
vaccines allowing for a single booster dose for all individuals 18 years of age
and older after completion of primary vaccination with any of the approved COVID-19
vaccines.The CDC also recommends that
adults should get a booster at least...
Booster interval and age updatedThe U.S. Food and Drug
Administration (FDA) and CDC authorizing the use of a Pfizer-BioNTech & Moderna COVID-19 Vaccine to shorten the time
between the completion of a primary series of the 2 vaccines and a booster dose
to at least 5 months after completion of the primary vaccination series for
individuals 12 yea...
SummaryWhat is already known about
this topic?Pregnant women with COVID-19 are
at increased risk for severe illness and adverse birth outcomes, yet many
remain reluctant to be vaccinated.What is added by this report?In a retrospective cohort of
>40,000 pregnant women, COVID-19 vaccination during pregnancy was not
associated with preterm bir...
The World Health Organization (WHO)
says early evidence suggests the omicron variant may be spreading faster than
the highly transmissible delta variant but brings with it less severe
coronavirus disease though it’s too early to make firm conclusions. Omicron Now in 57 Countries, Could Have Major Impact on Pandemic, Says
WHO.· New
corona...
A nationwide Spanish
cross-sectional study was conducted. Study included patients with cutaneous
reactions within 21 days of any dose of the approved vaccines at the time
of the study.Published in the British Journal of Dermatology
Evaluation of 405 cutaneous reactions after
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) va...
FDA authorized the emergency use of the Pfizer-BioNTech
COVID-19 Vaccine for the prevention of COVID19 to include
children 5 through 11 years of age.
Key points:
Effectiveness: Immune responses of
children 5 through 11 years of age were comparable to those of individuals
16 through 25 years of age. In addition, t...
Pfizer’s COVID-19 vaccine could
be authorized for ages 5-11 by the
end of October, according to Reuters. FDA may authorize COVID-19 vaccine for kids based on two
months of safety data. The timeline is based on the expectation that Pfizer
will have enough data from clinical trials to request FDA emergency use
authorization for the age group nea...
Russian health officials have approved a single-dose version
of the Sputnik V vaccine. Sputnik Light has showed nearly 80 per cent efficacy
in tests.
The single dose Sputnik Light vaccine demonstrated 79.4%
efficacy according to analyzed data taken from 28 days after the injection was
administered as part of Russia’s mass vaccination program...
A study by the University of
Oxford, published in the journal Cell, demonstrates that currently
available vaccines, including AstraZeneca’s COVID-19 vaccine, will provide
protection against the Delta (B.1.617.2) and Kappa (B1.617.1) variants;
formerly the ‘Indian’ variants.
The study, investigated the
ability of antibodies in the blood of...
Food and Drug Administration
advisory committee (US FDA) unanimously recommend the third shots to people age
65 and older and those at a high risk of suffering from severe illness if they
get the coronavirus.
Rejected a proposal to distribute
booster/third shots of Pfizer and BioNTech’s Covid-19 vaccine to the General Public. RemoveA...
Current recommendations from the Joint
Committee on Vaccination and Immunisation (JCVI) UK and the Royal College of
Obstetricians and Gynaecologists (RCOG) state that, all
pregnant women should be offered the COVID-19 vaccine at the same time as the
rest of the population, based on their age and clinical risk group.Vaccination is the best way t...
